CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Patterns of radiological progression in participants (pts) with embolization-eligible hepatocellular carcinoma (HCC) treated with durvalumab (D)+bevacizumab (B)+transarterial chemoembolization (TACE) and placebos+TACE: EMERALD-1 post hoc a…
DOI 10.1055/s-0045-1810980
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Roderburg, B Sangro, M Bouattour, J-W Park, M del Consuelo Díaz Romero, J P Erinjeri, G Alves, S Gu, A Manikhas, H Kuroda, T Suksombooncharoen, T Hoi Trung Vo, V S Ostwal, M Eastgate, G Vaccaro, R Griffin, S Ali, K Balaji, S L Chan
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2025
Jahrgang / SeitenJg. 63 · S. e553-e554
Kernaussage aus der Literatur
Abstract-Vorschau
Patterns of radiological progression in participants (pts) with embolization-eligible hepatocellular carcinoma (HCC) treated with durvalumab (D)+bevacizumab (B)+transarterial chemoembolization (TACE) and placebos+TACE: EMERALD-1 post hoc analysis
Zitieren
Zitierempfehlung
C Roderburg, B Sangro, M Bouattour, J-W Park, M del Consuelo Díaz Romero, J P Erinjeri, G Alves, S Gu, A Manikhas, H Kuroda, T Suksombooncharoen, T Hoi Trung Vo, V S Ostwal, M Eastgate, G Vaccaro, R Griffin, S Ali, K Balaji, S L Chan (2025) Patterns of radiological progression in participants (pts) with embolization-eligible hepatocellular carcinoma (HCC) treated with durvalumab (D)+bevacizumab (B)+transarterial chemoembolization (TACE) and placebos+TACE: EMERALD-1 post hoc analysis. Zeitschrift für Gastroenterologie, 63 (08), e553-e554. https://doi.org/10.1055/s-0045-1810980
Mit CareLit weiterarbeiten